160 related articles for article (PubMed ID: 37158186)
1. The association of allopurinol with persistent physical disability and frailty in a large community based older cohort.
Zhou Z; Ryan J; Nelson MR; Woods RL; Orchard SG; Zhu C; Gilmartin-Thomas JFM; Fravel MA; Owen AJ; Murray AM; Espinoza SE; Ernst ME
J Am Geriatr Soc; 2023 Sep; 71(9):2798-2809. PubMed ID: 37158186
[TBL] [Abstract][Full Text] [Related]
2. The Association between Frailty and Dementia-Free and Physical Disability-Free Survival in Community-Dwelling Older Adults.
Ekram ARMS; Ryan J; Espinoza SE; Newman AB; Murray AM; Orchard SG; Fitzgerald SM; McNeil JJ; Ernst ME; Woods RL
Gerontology; 2023; 69(5):549-560. PubMed ID: 36617406
[TBL] [Abstract][Full Text] [Related]
3. The Association between Metabolic Syndrome, Frailty and Disability-Free Survival in Healthy Community-dwelling Older Adults.
Saifuddin Ekram ARM; Espinoza SE; Ernst ME; Ryan J; Beilin L; Stocks NP; Ward SA; McNeil JJ; Shah RC; Woods RL
J Nutr Health Aging; 2023; 27(1):1-9. PubMed ID: 36651481
[TBL] [Abstract][Full Text] [Related]
4. The association between polypharmacy, frailty and disability-free survival in community-dwelling healthy older individuals.
Ekram ARMS; Woods RL; Ryan J; Espinoza SE; Gilmartin-Thomas JFM; Shah RC; Mehta R; Kochar B; Lowthian JA; Lockery J; Orchard S; Nelson M; Fravel MA; Liew D; Ernst ME
Arch Gerontol Geriatr; 2022; 101():104694. PubMed ID: 35349875
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Low-Dose Aspirin on Frailty Phenotype and Frailty Index in Community-Dwelling Older Adults in the ASPirin in Reducing Events in the Elderly Study.
Espinoza SE; Woods RL; Ekram ARMS; Ernst ME; Polekhina G; Wolfe R; Shah RC; Ward SA; Storey E; Nelson MR; Reid CM; Lockery JE; Orchard SG; Trevaks R; Fitzgerald SM; Stocks NP; Chan A; McNeil JJ; Murray AM; Newman AB; Ryan J
J Gerontol A Biol Sci Med Sci; 2022 Oct; 77(10):2007-2014. PubMed ID: 34758073
[TBL] [Abstract][Full Text] [Related]
6. The association between frailty and incident cardiovascular disease events in community-dwelling healthy older adults.
Ekram ARMS; Tonkin AM; Ryan J; Beilin L; Ernst ME; Espinoza SE; McNeil JJ; Nelson MR; Reid CM; Newman AB; Woods RL
Am Heart J Plus; 2023 Apr; 28():. PubMed ID: 37168270
[TBL] [Abstract][Full Text] [Related]
7. Allopurinol therapy in gout patients does not associate with beneficial cardiovascular outcomes: a population-based matched-cohort study.
Kok VC; Horng JT; Chang WS; Hong YF; Chang TH
PLoS One; 2014; 9(6):e99102. PubMed ID: 24897240
[TBL] [Abstract][Full Text] [Related]
8. Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes.
Singh JA; Ramachandaran R; Yu S; Curtis JR
BMC Cardiovasc Disord; 2017 Mar; 17(1):76. PubMed ID: 28288564
[TBL] [Abstract][Full Text] [Related]
9. Potentially inappropriate medication use is associated with increased risk of incident disability in healthy older adults.
Lockery JE; Collyer TA; Woods RL; Orchard SG; Murray A; Nelson MR; Stocks NP; Wolfe R; Moran C; Ernst ME;
J Am Geriatr Soc; 2023 Aug; 71(8):2495-2505. PubMed ID: 37039393
[TBL] [Abstract][Full Text] [Related]
10. Motor function is the primary driver of the associations of sarcopenia and physical frailty with adverse health outcomes in community-dwelling older adults.
Buchman AS; Leurgans SE; Wang T; Schnaider-Beeri M; Agarwal P; Dawe RJ; Delbono O; Bennett DA
PLoS One; 2021; 16(2):e0245680. PubMed ID: 33529220
[TBL] [Abstract][Full Text] [Related]
11. Association of Chronic Kidney Disease With Allopurinol Use in Gout Treatment.
Vargas-Santos AB; Peloquin CE; Zhang Y; Neogi T
JAMA Intern Med; 2018 Nov; 178(11):1526-1533. PubMed ID: 30304329
[TBL] [Abstract][Full Text] [Related]
12. Instruments to assess sarcopenia and physical frailty in older people living in a community (care) setting: similarities and discrepancies.
Mijnarends DM; Schols JM; Meijers JM; Tan FE; Verlaan S; Luiking YC; Morley JE; Halfens RJ
J Am Med Dir Assoc; 2015 Apr; 16(4):301-8. PubMed ID: 25530211
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study.
Zhang M; Solomon DH; Desai RJ; Kang EH; Liu J; Neogi T; Kim SC
Circulation; 2018 Sep; 138(11):1116-1126. PubMed ID: 29899013
[TBL] [Abstract][Full Text] [Related]
14. Long-term blood pressure variability and frailty risk in older adults.
Fravel MA; Ernst ME; Woods RL; Beilin L; Zhou Z; Orchard SG; Chowdhury E; Reid CM; Saifuddin Ekram A; Espinoza SE; Nelson MR; Stocks N; Polkinghorne KR; Wolfe R; Ryan J
J Hypertens; 2024 Feb; 42(2):244-251. PubMed ID: 38009310
[TBL] [Abstract][Full Text] [Related]
15. Ability of Self-Reported Frailty Components to Predict Incident Disability, Falls, and All-Cause Mortality: Results From a Population-Based Study of Older British Men.
Papachristou E; Wannamethee SG; Lennon LT; Papacosta O; Whincup PH; Iliffe S; Ramsay SE
J Am Med Dir Assoc; 2017 Feb; 18(2):152-157. PubMed ID: 27742583
[TBL] [Abstract][Full Text] [Related]
16. Is allopurinol use associated with an excess risk of osteoporotic fracture? A National Prescription Registry study.
Dennison EM; Rubin KH; Schwarz P; Harvey NC; Bone KW; Cooper C; Abrahamsen B
Arch Osteoporos; 2015; 10():36. PubMed ID: 26481934
[TBL] [Abstract][Full Text] [Related]
17. Validation of a Deficit-Accumulation Frailty Index in the ASPirin in Reducing Events in the Elderly Study and Its Predictive Capacity for Disability-Free Survival.
Ryan J; Espinoza S; Ernst ME; Ekram ARMS; Wolfe R; Murray AM; Shah RC; Orchard SG; Fitzgerald S; Beilin LJ; Ward SA; Williamson JD; Newman AB; McNeil JJ; Woods RL
J Gerontol A Biol Sci Med Sci; 2022 Jan; 77(1):19-26. PubMed ID: 34338761
[TBL] [Abstract][Full Text] [Related]
18. Impact of allopurinol use on urate concentration and cardiovascular outcome.
Wei L; Mackenzie IS; Chen Y; Struthers AD; MacDonald TM
Br J Clin Pharmacol; 2011 Apr; 71(4):600-7. PubMed ID: 21395653
[TBL] [Abstract][Full Text] [Related]
19. Frailty as a Major Factor in the Increased Risk of Death and Disability in Older People With Diabetes.
Castro-Rodríguez M; Carnicero JA; Garcia-Garcia FJ; Walter S; Morley JE; Rodríguez-Artalejo F; Sinclair AJ; Rodríguez-Mañas L
J Am Med Dir Assoc; 2016 Oct; 17(10):949-55. PubMed ID: 27600194
[TBL] [Abstract][Full Text] [Related]
20. Long-term allopurinol use decreases the risk of prostate cancer in patients with gout: a population-based study.
Shih HJ; Kao MC; Tsai PS; Fan YC; Huang CJ
Prostate Cancer Prostatic Dis; 2017 Sep; 20(3):328-333. PubMed ID: 28398294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
